SecBot SecBot
S-3ASR ·Filed May 22, 2026

CVS

CVS HEALTH Corp
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago SEC0001193125-26-236988
Notable filing: S-3ASR
Actionable Insight • Neutral

No actionable event, this shelf registration is standard treasury housekeeping for a large IG-rated company. Monitor for subsequent prospectus supplements that would signal an actual debt tap (likely for refinancing maturities, M&A funding, or general corporate needs). CVS had ~$119B market cap and recently filed Q1 2026 results (May 6) and an 8-K (May 18), no distress signals evident.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$90.55
T+0 close · May 22, 2026 · via day close
Latest settled
+3.43%
T+60 · $93.65
Vs SPY
+0.97%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 26 $90.55entry
  2. T+1 · 6mo ago +1.64%α +1.63% · $92.04
  3. T+5 · 6mo ago −1.19%α −2.41% · $89.47
  4. T+20 · 5mo ago +12.17%α +14.44% · $101.57
  5. T+60 · 3mo ago +3.43%α +0.97% · $93.65

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CVS Health filed an automatic shelf registration (S-3ASR) to register an indeterminate amount of debt securities (senior or subordinated) for future issuance. No specific offering is being made today, the filing establishes capacity for opportunistic debt capital markets access. Proceeds from any future issuance would be used for general corporate purposes. The filing itself is a routine administrative step with no immediate financial impact.

Key Facts

  • S-3ASR filed May 22, 2026 registering indeterminate amount of debt securities
  • Covers senior and subordinated debt to be issued under existing indentures
  • No specific offering size, price, or timing stated, pay-as-you-go registration fees under Rule 456(b) and 457(r)
  • Use of proceeds: general corporate purposes unless otherwise specified in future prospectus supplement
  • Registration effective immediately upon filing (well-known seasoned issuer status maintained)

Financial Impact

No offering being made, registration is shelf capacity only; any future offering would be via prospectus supplement with specific terms

debt

Risk Factors

  • Future debt issuance could increase leverage if proceeds are not used for refinancing
  • No immediate risk, filing merely creates shelf capacity

Market Snapshot

Exchange
NYSE
Sector
Retail-Drug Stores and Proprietary Stores
Analyst Consensus
79% bullish (33 analysts)

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 10 SEC documents filed with EDGAR.

DocumentAccession Number
S-3ASR Filing (Primary)0001193125-26-236988
Document: d74214dex251.htm0001193125-26-236988
Document: d74214dex252.htm0001193125-26-236988
Document: d74214dex51.htm0001193125-26-236988
Document: d74214dexfilingfees.htm0001193125-26-236988
Document: d74214dex231.htm0001193125-26-236988
Document: d74214dex151.htm0001193125-26-236988
Document: 0001193125-26-236988-index-headers.html0001193125-26-236988
Document: 0001193125-26-236988-index.html0001193125-26-236988
Document: 0001193125-26-236988.txt0001193125-26-236988

Track record

25 reports on CVS

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +32.33% at T+60 after the Apr 8, 2026 report. 7 of 9 went positive at some point.

Filters
  1. Nov 13, 20264d ago Court Ruling Neutral 3/10 No price data
  2. Nov 6, 202610d ago Insider Buy Bullish 4/10 Entry $85.25 Now $88.59 +3.92% settles Dec 8
  3. Nov 4, 202612d ago 8-K Neutral 6/10 Entry $79.96 Now $88.59 +10.79% settles Dec 3
  4. Nov 4, 202612d ago 8-K Bullish 6/10 Entry $79.96 Now $88.59 +10.79% settles Dec 3
  5. Oct 26, 202621d ago Institutional Cluster Neutral 3/10 Entry $92.53 Now $88.59 −4.26% settles Nov 23
  6. Oct 15, 20264w ago Press Release Neutral 2/10 Entry $92.58 to $89.79 Now $88.59 −4.31% ▼ −3.01% −1.11% vs SPY
  7. Sep 30, 20266w ago Press Release Neutral 2/10 Entry $85.20 to $90.33 Now $88.59 +3.98% ▲ +6.02% +5.32% vs SPY
  8. Aug 5, 202614w ago 8-K Bullish 8/10 Entry $99.12 to $97.23 Now $88.59 −10.62% ▼ −1.91% −1.31% vs SPY
  9. Jul 10, 202618w ago Press Release Neutral 2/10 Entry $104.15 to $95.46 Now $88.59 −14.94% ▼ −8.35% −10.77% vs SPY
  10. Jun 29, 202620w ago Court Ruling Bullish 5/10 Entry $103.58 to $107.74 Now $88.59 −14.47% ▲ +4.02% +4.30% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens Wed (10h 16m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 22, 2026